Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ HYDROGEN REFUELING SOLUTIONS (HRS) : HRS LAUNCHES THE IMPLEMENTATION OF ITS FIRST ENERGY BACKUP SOLUTION FOR... (Actusnews) +++ BALLARD POWER Aktie +3,26%

EUROFINS Aktie

 >EUROFINS Aktienkurs 
62.44 EUR    +0.3%    (TradegateBSX)
Ask: 62.94 EUR / 85 Stück
Bid: 62.58 EUR / 85 Stück
Tagesumsatz: 67 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EUROFINS Aktie über LYNX handeln
>EUROFINS Performance
1 Woche: +5,3%
1 Monat: -10,4%
3 Monate: -7,7%
6 Monate: +10,0%
1 Jahr: +9,8%
laufendes Jahr: +0,1%
>EUROFINS Aktie
Name:  EUROFINS SCIENTIFIC SE
Land:  Frankreich
Sektor:  Gesundheit
ISIN/ Wkn:  FR0014000MR3 / A2QJCT
Symbol/ Ticker:  ESF0 (Frankfurt)
Kürzel:  FRA:ESF0, ETR:ESF0, ESF0:GR
Index:  CAC40
Webseite:  https://www.eurofins.com/
Profil:  Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, specializing in testing and support services across multiple industries. It delivers comprehensive analytical solutions to the pharmaceutical, food, environmental, ..
>Volltext..
Marktkapitalisierung:  10615.97 Mio. EUR
Unternehmenswert:  15308.69 Mio. EUR
Umsatz:  7379.86 Mio. EUR
EBITDA:  1558.89 Mio. EUR
Nettogewinn:  480.25 Mio. EUR
Gewinn je Aktie:  2.67 EUR
Schulden:  5494.36 Mio. EUR
Liquide Mittel:  800.28 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.33
Umsatzwachstum:  4.96%
Gewinnwachstum:  16.83%
Dividende je Aktie:  0.72 EUR
Dividendenrendite:  1.2%
Dividendenschätzung:  1.2%
Div. Historie:  28.04.26 - 0.72€
28.04.25 - 0.6€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EUROFINS
Letzte Datenerhebung:  21.05.26
>EUROFINS Kennzahlen
Aktien/ Unternehmen:
Aktien: 170.53 Mio. St.
Frei handelbar: 60.71%
Rückkaufquote: 1.37%
Mitarbeiter: 65694
Umsatz/Mitarb.: 0.11 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 14.57%
Bewertung:
KGV: 24.13
KGV lG: 16.34
KUV: 1.5
KBV: 3.06
PEG-Ratio: 1.07
EV/EBITDA: 9.82
Rentabilität:
Bruttomarge: 11.22%
Gewinnmarge: 6.51%
Operative Marge: 11.22%
Managementeffizenz:
Gesamtkaprendite: 4.34%
Eigenkaprendite: 12.05%
 >EUROFINS Anleihen 
>EUROFINS Peer Group
Gesundheit
 
20.05.26 - 12:01
Name Bubbles Confirms Safety Standards with BPA-Free Certification for all Kids′ Name Labels (PR Newswire)
 
BALLSTON SPA, N.Y., May 20, 2026 /PRNewswire/ -- Name Bubbles, the leading U.S. manufacturer of custom name labels for kids, is proud to announce that its labels have been independently safety-tested and officially confirmed as BPA-free. The testing, conducted by Eurofins MTS Consumer......
18.05.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases From 11th May to 15th May 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   11/05/2026   FR0014000MR3   15 000   58.4581   CEUX EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   11/05/2026   FR0014000MR3   45 000   58.4506   XPAR EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   12/05/2026   FR0014000MR3   45 000   58.5943   XPAR EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   12/05/2026   FR0014000MR3   15 000   58.6612   CEUX EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   13/05/2026   FR0014000MR3   15 000   59.2622   CEUX EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   13/05/2026   FR0014000MR3   45 000   59.3247   XPAR EUROFINS SCIENTIFC   529900JEHFM47DYY3S57   14/05/2026   FR0014000MR3   30 000   58.8987   XPAR EUROFINS...
11.05.26 - 19:00
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name Sean Murray   2. Reason for the notification a) Position / status EVP, Life Testing North America b) Initial notification / amendment Initial   3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57     4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of tr...
11.05.26 - 17:51
Eurofins Scientific SE: Weekly Report on Share Repurchases From 04th May to 08th May 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 04/05/2026 FR0014000MR3 45 000 57.9715 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 04/05/2026 FR0014000MR3 15 000 57.9946 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 05/05/2026 FR0014000MR3 45 000 58.5531 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 05/05/2026 FR0014000MR3 15 000 58.5520 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 06/05/2026 FR0014000MR3 45 000 60.2065 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 06/05/2026 FR0014000MR3 15 000 60.2423 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 07/05/2026 FR0014000MR3 40 000 59.9996 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 07/05/2026 FR0014000MR3 20 000 60.0521 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 08/05/2026...
04.05.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 27th April to 30th April 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 27/04/2026 FR0014000MR3 35 000 62.5188 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 27/04/2026 FR0014000MR3 5 000 62.3938 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 28/04/2026 FR0014000MR3 5 000 60.3208 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 28/04/2026 FR0014000MR3 35 000 60.3662 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 29/04/2026 FR0014000MR3 45 000 58.6681 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 29/04/2026 FR0014000MR3 15 000 58.5297 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 30/04/2026 FR0014000MR3 17 000 57.9023 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 30/04/2026 FR0014000MR3 53 000 57.8054 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 30/04/2026 F...
27.04.26 - 23:51
XETR: DIVIDEND/INTEREST INFORMATION - 28.04.2026 - FR0014000MR3 (XETRA)
 
Das Instrument ESF0 FR0014000MR3 EUROFINS SCI.INH.EO 0,01 EQUITY wird ex Dividende/Zinsen gehandelt am 28.04.2026 The instrument ESF0 FR0014000MR3 EUROFINS SCI.INH.EO 0,01 EQUITY has its ex-dividend/interest day on 28.04.2026...
27.04.26 - 19:06
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF) (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Sean Murray 2. Reason for the notification a) Position / status EVP, Life Testing North America b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each...
27.04.26 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 23rd April to 24th April 2026 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 23/04/2026 FR0014000MR3 40 000 61.8744 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 23/04/2026 FR0014000MR3 10 000 61.9124 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 24/04/2026 FR0014000MR3 5 000 62.4335 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 24/04/2026 FR0014000MR3 35 000 62.3608 XPAR       TOTAL 90 000 62.0988   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts Eurofins Scientific SE...
24.04.26 - 17:51
Eurofins Launches Seventh Buy-Back Programme of Its Own Shares (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.5% of its share capital. The maximum amount meant for the repurchase of the Company's shares may not exceed a sum corresponding to an amount equivalent to the value of 4.5% of the shares composing the share capital of the Company as of the Board of Directors Meeting Date, on 23 April 2026. This seventh programme follows the sixth programme that took place between 25 April 2025 and 23 April 2026. The new programme is commencing on 24 April 2026 and will last until 23 April 2027 at the latest. The Company may at any time interrupt this programme in view of market conditions and/or the evolution of its investment strategy. The shares to be purchased under this programme will be used to hedge the Company's Long-Term Incentive plans but may also be cancelled, use...
22.04.26 - 15:54
Earnings Call Transkript: Eurofins Scientific verfehlt Umsatzprognose für Q1 2026 – Aktie bricht um 11 % ein (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.04.26 - 10:15
Eurofins shares tumble after big organic revenue growth miss in Q1 (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.04.26 - 08:30
Eurofins Q1 Organic Revenue Growth At 2.6%; Reiterates Objectives (AFX)
 
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins (EUFI.PA) reported first quarter revenues of 1.79 billion euros, an increase of 1.3% from a year ago. Organic revenue growth was 2.6%, which included ......
22.04.26 - 07:21
Eurofins Achieves Organic Growth of 2.6% in Q1 2026, Including Impact of Exceptionally Severe Weather; 2026 and Mid-Term Objectives Reiterated (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: The Eurofins (Paris:ERF) network of companies delivered steady growth despite significant temporary headwinds: Reported revenues in Q1 2026 totalled €1,789m, an increase of 1.3% vs Q1 2025. This was driven by both organic growth13 and acquisitions, with a -4.8% headwind from foreign exchange as the Euro strengthened against most currencies compared to the prior year quarter. Organic revenue growth13 in Q1 2026 was 2.6%, which includes a +0.1% adjustment for public working days; In Europe, organic growth13 was 1.7% (1.6% excluding public working days adjustment). Growth reflected headwinds from extreme weather in Northern Europe on Eurofins' Food & Feed and Environment Testing businesses, which was only partially recovered by the end of the quarter; the planned rationalisation of certain loss-making Clinical Diagnostics contracts in the former Synlab business in Spain and in Italy; continued softness in Biopharma Ancillary activities and not-yet-replaced CDM...
14.04.26 - 12:24
Eurofins Shares Rise after Selling Electronics Division to U.S. Safety Group (WSJ EN)
 
Eurofins Scientific shares jumped after the laboratory testing group agreed to sell its electrical and electronics testing division to Illinois-based UL Solutions....
14.04.26 - 12:00
Eurofins Shares Rise after Selling Electronics Division to U.S. Safety Group (WSJ EN)
 
Eurofins Scientific shares jumped after the French laboratory testing group agreed to sell its electrical and electronics testing division to Illinois-based UL Solutions....
14.04.26 - 10:00
Eurofins Scientific divests electrical testing business in €575M deal with UL Solutions (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.04.26 - 08:48
Eurofins Scientific To Divest Electrical & Electronic Testing Business (AFX)
 
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins Scientific SE (EUFI.PA, ERF.PA) announced the signing of an agreement to divest its Electrical & Electronic Testing business, or MET Labs, to UL Solut......
13.04.26 - 23:51
UL Solutions Inc. Broadens Portfolio with Agreement to Acquire Eurofins Scientific′s Electrical & Electronics Business (Business Wire)
 
Expands UL Solutions' global laboratory footprint and enhances commitment to TIC services for electrical safety and connected products Transaction expected to close in Q4 2026 subject to regulatory approvals and customary closing conditionsNORTHBROOK, Ill.--(BUSINESS WIRE)--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has entered into a definitive agreement to acquire the electrical and electronics (E&E) business (inclusive of the MET Labs certification mark) of Eurofins Scientific SE (“Eurofins”).1 The transaction expands UL Solutions' global footprint and is intended to enhance its testing, inspection and certification (TIC) business for electrical safety and connected products. Purchase price represents an enterprise value of approximately €575 million (approximately $670 million). Expected to be funded with cash on hand, including proceeds from the sale of the Company's Employee Health and Safety software business, and available capacity on the ...
13.04.26 - 22:21
UL Solutions Inc. Broadens Portfolio with Agreement to Acquire Eurofins Scientific′s Electrical & Electronics Business1 (Business Wire)
 
Expands UL Solutions' global laboratory footprint and enhances commitment to TIC services for electrical safety and connected products Transaction expected to close in Q4 2026 subject to regulatory approvals and customary closing conditionsNORTHBROOK, Ill.--(BUSINESS WIRE)--UL Solutions Inc. (NYSE: ULS), a global leader in applied safety science, today announced it has entered into a definitive agreement to acquire the electrical and electronics (E&E) business (inclusive of the MET Labs certification mark) of Eurofins Scientific SE (“Eurofins”). The transaction expands UL Solutions' global footprint and is intended to enhance its testing, inspection and certification (TIC) business for electrical safety and connected products. Purchase price represents an enterprise value of approximately €575 million (approximately $670 million). Expected to be funded with cash on hand, including proceeds from the sale of the Company's Employee Health and Safety software business, and available capacity on the C...
07.04.26 - 19:06
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name Laurent Lebras 2. Reason for the notification a) Position / status Group CFO b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; ...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Koste die Kleinigkeiten aus, das Große bietet meist zu wenig. - Karl Kröpfl
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!